Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Naturewise Biotech & Medicals Corporation (4732) Financial Statements

Naturewise Biotech & Medicals Corporation Financial Overview

Naturewise Biotech & Medicals Corporation's market cap is currently NT$739.69M. The company's EPS TTM is NT$-2.76; its P/E ratio is -5.40; and it has a dividend yield of 0.77%. Naturewise Biotech & Medicals Corporation has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 176.77MNT$ 224.32MNT$ 160.14MNT$ 228.59MNT$ 249.80M
Gross ProfitNT$ 85.70MNT$ 120.20MNT$ 87.38MNT$ 118.99MNT$ 134.90M
Operating IncomeNT$ -106.87MNT$ -12.04MNT$ 3.43MNT$ 26.35MNT$ 26.98M
EBITDANT$ -95.81MNT$ 7.46MNT$ 20.39MNT$ 37.29MNT$ 38.27M
Net IncomeNT$ -118.43MNT$ 897.00KNT$ 10.12MNT$ 30.02MNT$ 30.81M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 470.39MNT$ 614.73MNT$ 475.26MNT$ 493.98MNT$ 497.87M
Total AssetsNT$ 712.87MNT$ 840.59MNT$ 698.45MNT$ 692.60MNT$ 704.57M
Total DebtNT$ 12.71MNT$ 3.77MNT$ 10.68MNT$ 4.99MNT$ 12.56M
Net DebtNT$ -84.97MNT$ -316.18MNT$ -101.87MNT$ -93.98MNT$ -143.00M
Total LiabilitiesNT$ 72.09MNT$ 57.03MNT$ 64.89MNT$ 51.09MNT$ 80.22M
Stockholders' EquityNT$ 624.35MNT$ 741.02MNT$ 633.56MNT$ 641.51MNT$ 624.35M
Cash Flow
Free Cash FlowNT$ -113.44MNT$ -2.94MNT$ 61.57MNT$ 17.33MNT$ 28.89M
Operating Cash FlowNT$ -112.60MNT$ -2.79MNT$ 62.20MNT$ 13.85MNT$ 33.72M
Investing Cash FlowNT$ -80.02MNT$ 66.94MNT$ -19.72MNT$ -51.93MNT$ -32.05M
Financing Cash FlowNT$ -29.45MNT$ 142.83MNT$ -28.66MNT$ -22.36MNT$ -8.56M

Currency in TWD

Naturewise Biotech & Medicals Corporation Earnings and Revenue History

-200M0200M400M-100 %-50 %0 %50 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Naturewise Biotech & Medicals Corporation Liabilities to Assets

0300M600M900M6 %9 %12 %15 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Naturewise Biotech & Medicals Corporation Cash Flow

-200M-100M0100M200M300M201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Naturewise Biotech & Medicals Corporation Forecast EPS vs Actual EPS

Earnings >